Skip to main content
Premium Trial:

Request an Annual Quote

FYR Diagnostics Wins $618K NIH Grant to Develop Acquired Epilepsy Assay

NEW YORK — FYR Diagnostics said today that it has been awarded a National Institutes of Health grant worth up to $618,086 to develop a microRNA-based assay for the detection of acquired epilepsy.

Acquired epilepsy is a form of the neurological disorder that results from other conditions such as stroke, infections, and traumatic brain injury. 

With the two-year Phase I Small Business Innovation Research grant, FYR will perform studies in animal models to determine whether plasma miRNAs can serve as biomarkers of acquired epilepsy caused by brain injury — known as post-traumatic epilepsy — using an assay based on a proprietary isothermal chemistry called ultrasensitive DNA amplification reaction, or UDAR. 

FYR President Sarj Patel said in a statement that the Missoula, Montana-based firm intends to ultimately commercialize the assay.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.